Bullish & Foolish
Full NMTC fundamentals All 466 on the Survival Watch

NMTCNeuroOne Medical Technologies Corporation

Is NeuroOne Medical Technologies struggling financially?

Yes, by its own account. NeuroOne Medical Technologies told the SEC on 12 Jun 2026, in Form 10-Q/A, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Jun 2026

30/100

Fragile

Sector
Biotech/Pharma
Market cap
$18.5M
Source filing
10-Q/A 12 Jun 2026
Balance sheet
30 Jun 2026

Cash runway

  • 7months

    If the burn speeds up

    Empty by Jan 2027

  • 10months

    If it eases off

    Empty by Apr 2027

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$2.0M

÷

Cash burned over the last 12 months

$2.9M

What NeuroOne Medical Technologies told the SEC

…costs, and as such, it has been dependent on funding operations through the issuance of debt and sale of equity securities which previously resulted in substantial doubt regarding the Company’s ability to continue as a going concern. As of March 31, 2026, the Company had $ 2.8 million in cash and cash equivalents. The Company believes its current available cash and cash equivalents coupled with the anticipated…

NeuroOne Medical Technologies Corporation, Form 10-Q/A, filed 12 Jun 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

Other Biotech/Pharma companies that filed the doubt